News briefs | Dec. 2023

More than 80 people donate tissue during Nov. 12 event

Some of the think tank participants stayed overnight to attend the next day’s breast tissue collection to see first-hand how the well-oiled process works. A few even donated breast tissue. In all, more than 80 women and men donated tissue during the Nov. 12 event.

Since its founding in 2017, more than 5,000 people have donated breast tissue to the Komen Tissue Bank at the IU Simon Comprehensive Cancer Center.

Cancer Center Support Grant now submitted

The Cancer Center Support Grant, or CCSG, recently was submitted to the NCI. After beginning this arduous process more than a year ago, the 1,566-page grant application was submitted. It provides an in-depth look at the cancer center and its many outstanding contributions to research.

What does the grant provide? It benefits the center’s researchers because it’s an important source of funding for the shared facilities that are available to investigators. These facilities provide the center’s nearly 300 members with access to the highest quality of equipment and technology. The grant also supports center leadership and research-related administrative functions.

What's next?

Feb. 6, 2024: NCI site visit

April-May 2024: NCI review committee produces final summary statement for the National Cancer Advisory Board (NCAB).

June 2024: NCAB issues final summary statement.

September 2024: New NCI funding cycle begins.

Cancer Research Day is May 2

Save the date: Cancer Research Day, the cancer center’s signature research event, will be held Thursday, May 2, 2024. More details will be shared in early 2024.

Rachel Katzenellenbogen, MD (CPC), was named the recipient of the 2024 Norman J. Siegel Outstanding Science Award by The American Pediatric Society (APS) for her considerable contributions to pediatric science.

Jennifer E. Schwartz, MD, has been named associate dean for continuing education in healthcare professions  for IU School of Medicine. She will assume the role supporting the unit formerly referred to as Continuing Medical Education (CME), effective Feb. 1, 2024. She also was named interim division chief for the Division of Hematology/Oncology.

Leng Han, PhD (HHM), is lead author of “The Genetic, Pharmacogenomic, and Immune Landscapes Associated with Protein Expression across Human Cancers,” published in the journal Cancer Research. The paper was selected for the issue’s cover image.

#ResearchCuresCancer

Support Our Research